Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

IND.183: A phase II study of Sunitinib in patients with advanced malignant pleural mesothelioma Cohort 1 was 17 October 2008. Cohort 2 remains open.
http://www.ctg.queensu.ca/trials/ind/i183/183.html